Laura A. Pike

University of Colorado Anschutz Medical Campus

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer”.

First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0106

N/A

0.510DataRank · unranked

29 citations

Qiong Zhou, Hector Esquer, Laura A. Pike, Travis P. Broneske, Sébastien Rinaldetti +10 more

BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer

Cancers(2023)10.3390/cancers15020378

N/A

0DataRank · unranked

13 citations

Veronica L. Espinoza, Katelyn J. Hoff, Laura A. Pike, Vibha Sharma, Marie‐Claude Hofmann +4 more

CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models

International Journal of Molecular Sciences(2024)10.3390/ijms252313160

N/A

0DataRank · unranked

5 citations

Hector Esquer, Timothy Kellett, Sophia Clune, Paul Awolade, Laura A. Pike +4 more

Building a Diabetes Educator Program for Remote Patient Monitoring Billing

Journal of Diabetes Science and Technology(2024)10.1177/19322968241308920

N/A

0DataRank · unranked

3 citations

Annette Chmielewski, JEANNINE LEVERENZ, Shannon Lin, Barry Conrad, Anjoli Martinez-Singh +5 more